XBIT
Xbiotech·NASDAQ
--
--(--)
--
--(--)
6.14 / 10
Outperform
XBiotech's fundamentals score 6.14/10, with key strengths in interest coverage ratio (2/3), revenue growth (2/3), and asset valuation (3/3). The primary concern is Days sales outstanding (1/3), which may slow cash recovery. Weighted factors highlight revenue and asset advantages, but the elevated Days sales outstanding tempers enthusiasm. Net, the company presents a solid operational base with one notable working-capital risk.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-1.87%
1M Return-1.57%
Value72.55
Score1/3
Weight-1.87%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
PB-ROE
Value-0.58
Score3/3
Weight18.43%
1M Return12.83%
Value-0.58
Score3/3
Weight18.43%
1M Return12.83%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Value-0.26
Score3/3
Weight17.04%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Value78.47
Score2/3
Weight1.46%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-1.87%
1M Return-1.57%
Value72.55
Score1/3
Weight-1.87%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Value0.46
Score2/3
Weight13.59%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
Value-0.17
Score2/3
Weight13.60%
1M Return8.45%
PB-ROE
Value-0.58
Score3/3
Weight18.43%
1M Return12.83%
Value-0.58
Score3/3
Weight18.43%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.36%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Value92.66
Score2/3
Weight0.56%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Value-0.50
Score3/3
Weight25.20%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Value-0.07
Score2/3
Weight13.36%
1M Return8.41%
Is XBIT undervalued or overvalued?
- XBIT scores 6.14/10 on fundamentals and holds a Discounted valuation at present. Backed by its -10.68% ROE, 0.00% net margin, -2.57 P/E ratio, 0.43 P/B ratio, and 12.04% earnings growth, these metrics solidify its Outperform investment rating.
